Vaccines Archives – Treatment Action Group

Comments Delivered at the WHO Director-General’s TB Vaccine Accelerator Council

May 30, 2024
Dorrit Walsh

These are the remarks delivered by Mike Frick, TAG’s TB co-director, who was speaking as a civil society representative, at the 2nd meeting of the WHO Director-General’s TB Vaccine Accelerator Council in Geneva Switzerland.

2024 CROI Tuberculosis Research Round Up

March 14, 2024
Dorrit Walsh

Treatment Action Group (TAG) welcomes the tuberculosis (TB) data presented at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI). The highlights presented here cover the results of several phase II TB prevention and treatment trials.

Washington D.C. Community Consensus on the Earlier Inclusion of Pregnant Women and Persons in TB Research

February 28, 2024
Dorrit Walsh

In October 2023, sixteen members of the global TB community developed a consensus statement on the inclusion of pregnant and breastfeeding women and persons in TB treatment and vaccines research.

Statement from TAG, Global TB CAB on H56:IC31 Phase IIb Trial Results

December 21, 2023
Dorrit Walsh

This week, the Statens Serum Institut (SSI) and IAVI shared topline results of the phase IIb trial of H56:IC31, a subunit TB vaccine developed by SSI in Denmark consisting of four Mycobacterium tuberculosis antigens and the IC31 adjuvant made by Valneva.

TAG Condemns GSK Actions Surrounding Potential TB Vaccine Revealed by Bombshell ProPublica Report

October 6, 2023
Dorrit Walsh

TAG is appalled by the revelations set forth in Anna Marie Barry-Jester’s deeply reported investigation for ProPublica, “How a Big Pharma Company Stalled a Potentially Lifesaving Vaccine in Pursuit of Bigger Profits,” published online October 4.

TB Vaccine Development: The Next Chapter Starts Now

March 14, 2023
Dorrit Walsh

On Thursday, April 13, Treatment Action Group (TAG) presented this webinar about important developments in TB vaccine research.

Treatment Action Group Statement on NYC DOHMH Monkeypox Vaccination Announcement

June 23, 2022
Dorrit Walsh

In response to this morning's announcement by the New York City Department of Health and Mental Hygiene (NYC DOHMH) that the DOHMH would open a temporary monkeypox vaccination clinic at the Chelsea Sexual Health Clinic in New York, Treatment Action Group's Executive Director, Mark Harrington, and TAG HIV Project Director Riko A. Boone, MSW, MPH, MA, said:

Let’s Talk! HIV Vaccines 101

May 19, 2022
Dorrit Walsh

On May 18, 2022, Treatment Action Group (TAG), the Black AIDS Institute (BAI), and the Southern AIDS Coalition (SAC) participated in this fun and informative Instagram Live discussion commemorating HIV Vaccine Awareness. Day.

TB Vaccine Advocacy Roadmap Calls for Increased EU Funding for TB Vaccine Development

February 16, 2022
Dorrit Walsh

TAG stands proudly alongside the TB community to issue this press statement calling for increasing European funding for TB vaccine development, just before the sixth Global Forum on TB Vaccines convenes in Toulouse, France.

graphic from Breaking Barriers summary that shows why covid-19 and HIV remain prevalent in U.S. communities of color - structural racism pathways are: income, homelessness, unemployment, residental segregation, insurance-healthcare access, incarceration, provider bias, federal laws, and local policies

TAG and COVID-19 Prevention Network Fact Sheets

October 19, 2021
Dorrit Walsh

These three fact sheets were developed by TAG in partnership with the COVID-19 Prevention Network (CoVPN) and the Black AIDS Institute (BAI), and they aim to foster community understanding of COVID-19 vaccine research and development, as well as highlight community perspectives on the topic.